In conclusion, we have identified 5 prognostic risk-associated ARGs (HDAC1, RHEB, ATIC, SPNS1 and SQSTM1) by correlating the molecular signature of ARG with clinical outcomes of HCC patients. This evidence concerns the gene ATIC and hepatocellular carcinoma.